Pricing

RegeneRX Biopharmaceuticals, Inc. (RGRX)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Employees:
3
15245 SHADY GROVE ROAD, SUITE 470, ROCKVILLE, MD 20850
301-208-9191
    Formally known as:
  • Regenerx Biopharmaceuticals Inc.
Stock Split History
DateRatio
2023-08-14 1:100
RegeneRx Biopharmaceuticals, Inc. focuses on the development of therapeutic peptide, thymosin beta 4, for tissue and organ protection, repair, and regeneration. The company is developing RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available